The Anti HEV-IgM test detects immunoglobulin M (IgM) antibodies specific to hepatitis E virus (HEV), indicating acute or recent infection. It aids in diagnosing acute hepatitis E and distinguishing it from other causes of acute hepatitis. Interpretation considers clinical context and may involve additional testing for confirmation.

The HBeAg test is generally low-risk, involving a blood sample to detect hepatitis B e antigen. Risks are minimal, such as discomfort or bruising at the blood collection site. Interpretation is essential in the context of other hepatitis B markers for accurate diagnosis and management.

The HBeAg test typically reports results as positive or negative. A positive result indicates the presence of hepatitis B e antigen, suggesting active viral replication and high infectivity. A negative result suggests absence of the antigen, indicating lower viral replication and reduced infectivity. Interpretation should consider clinical context and other hepatitis B markers for accurate assessment.